| |
|
|
|
|
|
|
|
|
1. |
Record Nr. |
UNINA9910985678203321 |
|
|
Autore |
Balon Richard |
|
|
Titolo |
Pocket guide to emergent and serious adverse events in psychopharmacology |
|
|
|
|
|
|
|
Pubbl/distr/stampa |
|
|
Washington, D.C., : American Psychiatric Association Publishing, 2023 |
|
©2023 |
|
|
|
|
|
|
|
|
|
ISBN |
|
|
|
|
|
|
|
|
Edizione |
[1st ed.] |
|
|
|
|
|
Descrizione fisica |
|
1 Online-Resource (238 Seiten) |
|
|
|
|
|
|
Altri autori (Persone) |
|
|
|
|
|
|
Disciplina |
|
|
|
|
|
|
Soggetti |
|
Psychotropic Drugs - adverse effects |
Handbook |
|
|
|
|
|
|
|
|
Lingua di pubblicazione |
|
|
|
|
|
|
Formato |
Materiale a stampa |
|
|
|
|
|
Livello bibliografico |
Monografia |
|
|
|
|
|
Nota di contenuto |
|
Cover -- Half Title -- Title -- Copyright -- Contents -- Contributors -- Introduction -- Chapter 1 Acute Dystonia -- Chapter 2 Agitation -- Chapter 3 Agranulocytosis With Clozapine and Other Psychotropic Medications -- Chapter 4 Benzodiazepines in Combination With Opioids: Therapeutic Benefit Versus Fatal Overdose -- Chapter 5 Cardiac Emergencies Such as Arrhythmias, QTc Prolongation, and Cardiomyopathy -- Chapter 6 Discontinuation of Psychotropic Medications -- Chapter 7 Hepatotoxicity of Psychotropic Medications -- Chapter 8 Hypertensive Crisis Associated With Monoamine Oxidase Inhibitors -- Chapter 9 Hyponatremia, Especially in Older Adults -- Chapter 10 Neuroleptic Malignant Syndrome -- Chapter 11 Ocular Side Effects of Psychotropic Medications -- Chapter 12 Overdoses of Psychotropic Medications -- Chapter 13 Polypharmacy and Acute Side Effects -- Chapter 14 Pregnancy and Use of Psychotropic Medication -- Chapter 15 Seizure Risk Management -- Chapter 16 Serotonin Syndrome -- Chapter 17 Substances With Addictive Potential and Psychotropic Medications -- Chapter 18 Tardive Dyskinesia -- Index. |
|
|
|
|
|
|
|
|
Sommario/riassunto |
|
This book summarizes current knowledge of adverse events from acute dystonia and cardiac emergencies to hepatotoxicity and ocular side effects. Readers will come away with a better understanding of the |
|
|
|
|
|
|
|
|
|
|
recognition and detection of adverse events in psychopharmacology, culprit medications, assessment, management, and follow-up treatment. |
|
|
|
|
|
| |